205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-23.59%
Both companies show declining cash positions (-23.59% vs ON's -8.54%). Seth Klarman would examine if this reflects broader market conditions or operational challenges.
No Data
No Data available this quarter, please select a different quarter.
-23.59%
Cash + STI yoy ≥ 1.5x ON's -6.17%. David Dodd might see it as a strategic cash buffer advantage. Evaluate deployment plans.
6.33%
Receivables growth 50-75% of ON's 12.36%. Bruce Berkowitz would note relatively tighter receivables. Check if sales remain robust.
3.96%
Inventory growth above 1.5x ON's 0.43%. Michael Burry might suspect a looming inventory glut. Check free cash flow impact.
-25.51%
Other current assets growth < half of ON's 24.29%. David Dodd sees a leaner approach to short-term items.
-1.27%
Below half of ON's 0.39%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
4.93%
Below half ON's -3.25%. Michael Burry sees potential underinvestment risk unless there's a valid reason (asset-light model).
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.09%
Less than half of ON's -6.67%. David Dodd sees fewer expansions in non-core assets. Possibly a simpler focus.
5.33%
Below half of ON's -2.20%. Michael Burry might suspect stagnation or lack of resources for expansions.
No Data
No Data available this quarter, please select a different quarter.
2.15%
Below half of ON's -0.96%. Michael Burry sees a potential red flag for stagnation or capital shortage.
11.66%
Less than half of ON's -4.49%. David Dodd sees a more disciplined AP approach or lower volume.
76.00%
Higher Short-Term Debt Growth compared to ON's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.17%
Exceeding 1.5x ON's 1.11%. Michael Burry suspects ballooning short-term obligations vs. competitor.
6.62%
Less than half of ON's -1.06%. David Dodd sees a more disciplined short-term liability approach.
1.95%
Above 1.5x ON's 0.13%. Michael Burry suspects significant leverage additions. Check coverage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.37%
Less than half of ON's -4.93%. David Dodd notes more conservative expansions in non-current obligations.
3.32%
Less than half of ON's -0.67%. David Dodd sees a more conservative approach to non-current liabilities.
No Data
No Data available this quarter, please select a different quarter.
5.12%
Less than half of ON's -0.77%. David Dodd sees far fewer liability expansions relative to competitor.
No Data
No Data available this quarter, please select a different quarter.
-1.00%
Both ON and the company show zero Retained Earnings Growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.57%
0.5-0.75x ON's -1.11%. Martin Whitman is wary of lagging equity growth vs. competitor.
2.15%
Below half ON's -0.96%. Michael Burry sees significant shrinkage or inactivity vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
4.84%
Above 1.5x ON's 0.13%. Michael Burry sees a major jump. Investigate leverage rationale.
54.51%
1.25-1.5x ON's 39.54%. Martin Whitman is wary of heavier net leverage vs. competitor.